期刊文献+

Current knowledge on diabetic retinopathy from human donor tissues 被引量:21

Current knowledge on diabetic retinopathy from human donor tissues
下载PDF
导出
摘要 According to the American Diabetes Association,diabetes was the seventh leading cause of death,and diabetic retinopathy the leading cause of blindness in working age adults in the United States in 2010.Diabetes is characterized by hyperglycemia associated with either hypoinsulinemia or insulin resistance,and over time,this chronic metabolic condition may lead to various complications including kidney failure,heart attacks,and retinal degeneration.In order to better understand the molecular basis of this disease and its complications,animal models have been the primary approach used to investigate the effects of diabetes on various tissues or cell types of the body,including the retina.However,inherent to these animal models are critical limitations that make the insight gained from these models challenging to apply to the human pathology.These difficulties in translating the knowledge obtained from animal studies have led a growing number of research groups to explore the diabetes complications,especially diabetic retinopathy,on tissues from human donors.This review summarizes the data collected from diabetic patients at various stages of diabetic retinopathy and classifies the data based upon their relevance to the main aspects of diabetic retinopathy:retinal vasculature dysfunction,inflammation,and neurodegeneration.This review discusses the importance of those studies to discriminate and establish the relevance of the findings obtained from animal models but also the limitations of such approaches. According to the American Diabetes Association, diabetes was the seventh leading cause of death, and diabetic retinopathy the leading cause of blindness in working age adults in the United States in 2010. Diabetes is characterized by hyperglycemia associated with either hypoinsulinemia or insulin resistance, and over time, this chronic metabolic condition may lead to various complications including kidney failure, heart attacks,and retinal degeneration. In order to better understandthe molecular basis of this disease and its complications,animal models have been the primary approach usedto investigate the effects of diabetes on various tissuesor cell types of the body, including the retina. However,inherent to these animal models are critical limitationsthat make the insight gained from these modelschallenging to apply to the human pathology. Thesedifficulties in translating the knowledge obtained fromanimal studies have led a growing number of researchgroups to explore the diabetes complications, especiallydiabetic retinopathy, on tissues from human donors.This review summarizes the data collected from diabeticpatients at various stages of diabetic retinopathy andclassifies the data based upon their relevance to themain aspects of diabetic retinopathy: retinal vasculaturedysfunction, inflammation, and neurodegeneration. Thisreview discusses the importance of those studies todiscriminate and establish the relevance of the findingsobtained from animal models but also the limitations ofsuch approaches.
出处 《World Journal of Diabetes》 SCIE CAS 2015年第2期312-320,共9页 世界糖尿病杂志(英文版)(电子版)
关键词 RETINA Diabetic RETINOPATHY HUMAN DONOR PHYSIOPATHOLOGY Vascular disease Inflammation NEURODEGENERATION Retina Diabetic retinopathy Human donor Physiopathology Vascular disease Inflammation Neurodegeneration
  • 相关文献

参考文献62

  • 1Jackson GR, Scott IU, Quillen DA, Walter LE, Gardner TW. Innerretinal visual dysfunction is a sensitive marker of non-proliferativediabetic retinopathy. Br J Ophthalmol 2012; 96: 699-703 [PMID:22174096 DOI: 10.1136/bjophthalmol-2011-300467].
  • 2Funatsu H, Noma H, Mimura T, Eguchi S, Hori S. Associationof vitreous inflammatory factors with diabetic macular edema.Ophthalmology 2009; 116: 73-79 [PMID: 19118698 DOI: 10.1016/j.ophtha.2008.09.037].
  • 3Greenstein VC, Chen H, Hood DC, Holopigian K, Seiple W, CarrRE. Retinal function in diabetic macular edema after focal laserphotocoagulation. Invest Ophthalmol Vis Sci 2000; 41: 3655-3664[PMID: 11006264].
  • 4Bresnick GH, De Venecia G, Myers FL, Harris JA, Davis MD.Retinal ischemia in diabetic retinopathy. Arch Ophthalmol 1975;93: 1300-1310 [PMID: 1200895 DOI: 10.1001/archopht.1975.01010020934002].
  • 5Valsania P, Warram JH, Rand LI, Krolewski AS. Differentdeterminants of neovascularization on the optic disc and on theretina in patients with severe nonproliferative diabetic retinopathy.Arch Ophthalmol 1993; 111: 202-206 [PMID: 7679270 DOI:10.1001/archopht.1993.01090020056023].
  • 6Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinalmicrovascular cells in human and experimental diabetic retinopathy.J Clin Invest 1996; 97: 2883-2890 [PMID: 8675702 DOI: 10.1172/JCI118746].
  • 7Li W, Yanoff M, Liu X, Ye X. Retinal capillary pericyte apoptosisin early human diabetic retinopathy. Chin Med J (Engl) 1997; 110:659-663 [PMID: 9642318].
  • 8Boeri D, Maiello M, Lorenzi M. Increased prevalence of microthrombosesin retinal capillaries of diabetic individuals. Diabetes 2001;50: 1432-1439 [PMID: 11375345 DOI: 10.2337/diabetes.50.6.1432].
  • 9Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Liou GI, Caldwell RW. Vascular endothelialgrowth factor and diabetic retinopathy: role of oxidative stress. CurrDrug Targets 2005; 6: 511-524 [PMID: 16026270 DOI: 10.2174/1389450054021981].
  • 10Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES,Ferrara N, Folkman J, D’Amore PA, Miller JW. Inhibition ofvascular endothelial growth factor prevents retinal ischemiaassociatediris neovascularization in a nonhuman primate. ArchOphthalmol 1996; 114: 66-71 [PMID: 8540853 DOI: 10.1001/archopht.1996.01100130062010].

同被引文献87

引证文献21

二级引证文献159

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部